ICD-10 Specific code E61.1: Iron deficiency

The iron complex ferric carboxymaltose is designed to provide, in a controlled way, utilisable iron for the iron transport and storage proteins in the body (transferrin and ferritin, respectively). Ferric carboxymaltose treatment results in an increase in reticulocyte count, serum ferritin levels and TSAT levels to within normal ranges.

Iron is an essential constituent of the body, being necessary for haemoglobin formation and for the oxidative processes of living tissues. More than 80% of the iron present in the body is involved in the support of red blood cell production. Ferrous gluconate is indicated for the prevention and treatment of iron deficiency states.

Ferrous glycine sulfate is a medicinal product for the treatment of iron deficiency. It contains iron (Fe2+) in a form that the body can easily absorb and utilize and is therefore suitable to eliminate symptoms caused by iron deficiency. Like all iron preparations, ferrous glycine sulfate has no effects on erythropoiesis or anaemia that is not due to iron deficiency.

Iron sulphate is a co-factor of various enzymes necessary for the transfer of energy (eg. cytochrome oxidase, xanthine oxidase). Iron is also present in hemoglobin and myoglobin, which are essential for the transport and use of oxygen.